AstraZeneca PLC (GB:AZN)
LSE:AZN

AstraZeneca (GB:AZN) Stock Price & Analysis

67 Followers

AZN Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range8,024.43p - 11,886.00p
Previous Close10,578p
Volume366.03K
Average Volume (3M)2.08M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$4.90B
Total Debt (Recent Filing)$29.30B
Price to Earnings (P/E)107.6
Beta0.09
Next EarningsFeb 09, 2023
Dividend Yield1.97 (2.1%)
1Y Price Target12,362.50p
EPS (TTM)1.11
Shares Outstanding1,549,818,422
R-Squared0.09
Standard Deviation0.06
10 Day Avg. Volume2,944,327
30 Day Avg. Volume2,084,857
Price to Book (P/B)-7.37
Price to Sales (P/S)3.86
Price to Cash Flow (P/CF)23.50
P/FCF Ratio1133.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside17.31% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering13


Financials

Annual

AZN FAQ

What was AstraZeneca’s price range in the past 12 months?
AstraZeneca lowest stock price was 8024.43p and its highest was 11886.00p in the past 12 months.
    What is AstraZeneca’s market cap?
    Currently, no data Available
    When is AstraZeneca’s upcoming earnings report date?
    AstraZeneca’s upcoming earnings report date is Feb 09, 2023 which is in 3 days.
      How were AstraZeneca’s earnings last quarter?
      AstraZeneca released its earnings results on Nov 10, 2022. The company reported 1.385p earnings per share for the quarter, beating the consensus estimate of 1.258p by 0.127p.
        Is AstraZeneca overvalued?
        According to Wall Street analysts AstraZeneca’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AstraZeneca pay dividends?
          AstraZeneca pays a Annually dividend of 76.4p which represents an annual dividend yield of 2.1%. See more information on AstraZeneca dividends here
            What is AstraZeneca’s EPS estimate?
            AstraZeneca’s EPS estimate is 1.12p.
              How many shares outstanding does AstraZeneca have?
              AstraZeneca has 1,549,818,500 shares outstanding.
                What happened to AstraZeneca’s price movement after its last earnings report?
                AstraZeneca reported an EPS of 1.385p in its last earnings report, beating expectations of 1.258p. Following the earnings report the stock price went up 2.877%.
                  Which hedge fund is a major shareholder of AstraZeneca?
                  Currently, no hedge funds are holding shares in GB:AZN

                  ---

                  AstraZeneca Stock Smart Score

                  7
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  29.55%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  5.62%
                  Trailing 12-Months
                  Asset Growth
                  6.10%
                  Trailing 12-Months
                  The AstraZeneca Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  AstraZeneca PLC

                  A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  GlaxoSmithKline
                  Hikma Pharmaceuticals
                  Dechra Pharmaceuticals
                  Indivior

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis